Abstract
Iatrogenic hypoglycemia causes recurrent morbidity in most people with type 1 diabetes and many with type 2 diabetes, and it is sometimes fatal. The barrier of hypoglycemia generally precludes maintenance of euglycemia over a lifetime of diabetes and thus precludes full realization of euglycemia's long-term benefits. While the clinical presentation is often characteristic, particularly for the experienced individual with diabetes, the neurogenic and neuroglycopenic symptoms of hypoglycemia are nonspecific and relatively insensitive; therefore, many episodes are not recognized. Hypoglycemia can result from exogenous or endogenous insulin excess alone. However, iatrogenic hypoglycemia is typically the result of…
Citation impact
949
total citations
- FWCI
- 19.54
- Percentile
- 100%
- References
- 259
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Hypoglycemia
- Medicine
- Glucagon
- Diabetes mellitus
- Insulin
- Internal medicine
- Type 1 diabetes
- Pure autonomic failure
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.